
Ondine Biomedical Inc. (OBI.L)
OBI.L Stock Price Chart
Explore Ondine Biomedical Inc. interactive price chart. Choose custom timeframes to analyze OBI.L price movements and trends.
OBI.L Company Profile
Discover essential business fundamentals and corporate details for Ondine Biomedical Inc. (OBI.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
6 Dec 2021
Employees
18.00
Website
https://www.ondinebio.comCEO
Carolyn M. Cross MBA
Description
Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.
OBI.L Financial Timeline
Browse a chronological timeline of Ondine Biomedical Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 15 May 2025
Earnings released on 30 Sept 2024
Earnings released on 29 Jun 2024
EPS came in at -£0.02, while revenue for the quarter reached £499.76K.
Earnings released on 7 Jun 2024
Earnings released on 28 Feb 2024
Earnings released on 31 Dec 2023
EPS came in at -£0.02, while revenue for the quarter reached £456.75K.
Earnings released on 10 Aug 2023
Earnings released on 30 Jun 2023
EPS came in at -£0.02, while revenue for the quarter reached £257.33K, beating expectations by +0.69%.
Earnings released on 31 Dec 2022
EPS came in at -£0.04, while revenue for the quarter reached £240.14K.
Earnings released on 27 Sept 2022
EPS came in at -£0.03, while revenue for the quarter reached £167.15K.
Earnings released on 30 Jun 2022
EPS came in at -£0.03, while revenue for the quarter reached £158.66K.
OBI.L Stock Performance
Access detailed OBI.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.